Page last updated: 2024-08-25

arjunolic acid and Kidney Diseases

arjunolic acid has been researched along with Kidney Diseases in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sherif, IO1
Pal, PB; Pal, S; Sarkar, A; Sil, PC1
Al-Gayyar, MM; Eladl, MA; Elsherbiny, NM1

Other Studies

3 other study(ies) available for arjunolic acid and Kidney Diseases

ArticleYear
Amelioration of cisplatin-induced nephrotoxicity in rats by triterpenoid saponin of Terminalia arjuna.
    Clinical and experimental nephrology, 2015, Volume: 19, Issue:4

    Topics: Animals; Antineoplastic Agents; Biomarkers; Cell Adhesion Molecules; Cisplatin; Drug Evaluation, Preclinical; Kidney; Kidney Diseases; Kidney Function Tests; Male; NF-kappa B; Oxidative Stress; Phytotherapy; Plant Extracts; Proto-Oncogene Proteins c-bcl-2; Rats, Sprague-Dawley; Terminalia; Transforming Growth Factor beta; Triterpenes

2015
Protective effect of arjunolic acid against atorvastatin induced hepatic and renal pathophysiology via MAPK, mitochondria and ER dependent pathways.
    Biochimie, 2015, Volume: 112

    Topics: Animals; Apoptosis; Atorvastatin; Chemical and Drug Induced Liver Injury; Endoplasmic Reticulum; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney; Kidney Diseases; Liver; Male; MAP Kinase Signaling System; Mice; Mitochondria, Liver; Oxidative Stress; Triterpenes

2015
Renal protective effects of arjunolic acid in a cisplatin-induced nephrotoxicity model.
    Cytokine, 2016, Volume: 77

    Topics: Animals; Antineoplastic Agents; Apoptosis; Caspases; Cisplatin; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Gene Expression; Interleukin-1beta; Kidney; Kidney Diseases; Kidney Function Tests; Male; NF-kappa B; Phytotherapy; Protective Agents; Protein Serine-Threonine Kinases; Rats, Sprague-Dawley; Receptor, Transforming Growth Factor-beta Type I; Receptors, Transforming Growth Factor beta; Reverse Transcriptase Polymerase Chain Reaction; Terminalia; Transforming Growth Factor beta1; Triterpenes; Tumor Necrosis Factor-alpha

2016